Epidemiological and experimental data suggest that non-steroidal anti- inflammatory drugs (NSAIDs), including aspirin, have anti-neoplastic properties in the large bowel. Since neoplastic polyps (adenomas) of the large bowel are recognized as pre-malignant lesions and therefore are effective endpoints for the testing of preventive interventions, we propose a randomized, double-blind placebo controlled trial of the efficacy of aspirin in preventing recurrence of neoplastic polyps of the large bowel. This will be a collaborative study involving 8 clinical centers and a coordinating center. Subjects will have had at least one neoplastic polyp removed in the three months before enrollment, with no known polyps remaining in the large bowel, and no contraindications to aspirin use. After a run-in period of 2 months, 870 subjects will be randomized to receive either placebo, 80 mg or aspirin daily, or 325 mg aspirin daily. All subjects will be monitored for compliance and toxicity at six month intervals, and will receive a complete colonoscopic examination three years after the qualifying exam. At all lower gastrointestinal endoscopies, all raised mucosal lesions in the bowel will be removed and examined histologically. The primary analysis will be a comparison of the risk of recurrence of neoplastic polyps in the two aspirin groups versus the placebo group during the period between randomization and the 3-year exam. In secondary analyses, differences between the two aspirin doses will be investigated, and the effect of aspirin use on the size and number of neoplastic polyps will be investigated. The study will have at least 90% power to detect a 40: reduction in polyp recurrence risk between either of the 2 aspirin groups and the placebo group, assuming a 40% recurrence risk in the placebo group (as suggested by our previous studies). Aspirin is being increasingly used as a preventive agent against cardiovascular diseases, and this study will elucidate whether this intervention will also prevent colorectal neoplasms. The study will also help elucidate the biology of large bowel carcinogenesis by defining the impact of a prostaglandin synthetase inhibitor on the occurrence of neoplastic polyps.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA059005-05S2
Application #
2848359
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Perloff, Marjorie
Project Start
1993-09-30
Project End
1998-11-30
Budget Start
1998-08-01
Budget End
1998-11-30
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Passarelli, M N; Barry, E L; Zhang, D et al. (2018) Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas. Br J Dermatol 179:337-344
Fedirko, Veronika; McKeown-Eyssen, Gail; Serhan, Charles N et al. (2017) Plasma lipoxin A4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas. Mol Carcinog 56:1977-1983
Rees, Judy R; Morris, Carolyn B; Peacock, Janet L et al. (2017) Unmetabolized Folic Acid, Tetrahydrofolate, and Colorectal Adenoma Risk. Cancer Prev Res (Phila) 10:451-458
Anderson, Joseph C; Baron, John A; Ahnen, Dennis J et al. (2017) Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome. Gastroenterology 152:1933-1943.e5
Pohl, Heiko; Robertson, Douglas J; Mott, Leila A et al. (2016) Association between adenoma location and risk of recurrence. Gastrointest Endosc 84:709-16
Liu, Lin; Messer, Karen; Baron, John A et al. (2016) A prognostic model for advanced colorectal neoplasia recurrence. Cancer Causes Control 27:1175-85
Filiberti, Rosa; Fontana, Vincenzo; De Ceglie, Antonella et al. (2015) Smoking as an independent determinant of Barrett's esophagus and, to a lesser degree, of reflux esophagitis. Cancer Causes Control 26:419-29
Wallace, Kristin; Burke, Carol A; Ahnen, Dennis J et al. (2015) The association of age and race and the risk of large bowel polyps. Cancer Epidemiol Biomarkers Prev 24:448-53
Figueiredo, Jane C; Crockett, Seth D; Snover, Dale C et al. (2015) Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum. Cancer Causes Control 26:377-86
Fedirko, Veronika; Bradshaw, Patrick T; Figueiredo, Jane C et al. (2015) Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS). Cancer Prev Res (Phila) 8:1061-8

Showing the most recent 10 out of 57 publications